Bizarre Patents
Pillow with retractable umbrella
A pillow assembly having a supporting assembly and a retractable umbrella assembly that is easily transportable and allows a user to support his/her head while covering their face from sunlight.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7560429 | Orodispersible dosage forms of desmopressin acetate Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin... | 07/14/2009 |
| 7557082 | Treatment with cyclosporin A Disclosed herein is a method comprising administering cyclosporin A topically to an eye of a person for the purpose of treating or preventing loss of vision from keratoconus. ... | 07/07/2009 |
| 7550431 | Spatially-defined macrocycles incorporating peptide bond surrogates Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In parti... | 06/23/2009 |
| 7538085 | Peptide deformylase inhibitors as novel antibiotics A macrocyclic peptide deformylase (PDF) inhibitor comprising a peptide or peptide mimetic having three residues, P1′, P2′, and P3′, wherein P2′ connects P1′ and P3′, wherein P1′ and P3′ each have a side chain, and wherein the side chains on P1′ and... | 05/26/2009 |
| 7538084 | Cyclosporins The compounds of the present invention are represented by the chemical structure found in Formula I: Formula ... | 05/26/2009 |
| 7521420 | Macrocyclic antagonists of the motilin receptor The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: wherein R1, R2, R3, R4, R5 | 04/21/2009 |
| 7521421 | Deuterated cyclosporine analogs and methods of making the same Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical a... | 04/21/2009 |
| 7517853 | Somatostatin-dopamine chimeric analogs The invention features somatostatin-dopamine chimeric analogs and methods relating to their therapeutic use for the treatment of neoplasia, acromegaly, and other conditions. ... | 04/14/2009 |
| 7517854 | Melanocortin receptor agonists Small cyclic peptides of the formula X1-X2-X3-X4-X5-X6-X7-R1 comprising 7-12 amino acid residues are provided. Said peptides are MC4 receptor agonists, and thus useful in the treatment of obesity and related diseases. ... | 04/14/2009 |
| 7511014 | Cyclosporin galenic forms Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10. ... | 03/31/2009 |
| 7501393 | Pharmaceutical compositions comprising cyclosporins A composition is described herein comprising cyclosporin A, polysorbate 80, a polyoxyethylene stearate, and an oil; wherein the composition is an emulsion which is ophthalmically acceptable. Methods of treating diseases or conditions using said compositions, and med... | 03/10/2009 |
| 7498302 | Disulfide prodrugs and linkers and stabilizers useful therefor The present invention provides analogues of duocarmycins that are potent cytotoxins. Also provided are peptidyl and disulfide linkers that are cleaved in vivo. The linkers are of use in forming prodrugs and conjugates of the cytotoxins of the invention as well as ot... | 03/03/2009 |
| 7476653 | Macrocyclic modulators of the ghrelin receptor The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective modulators of the ghrelin receptor (growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and variants thereof). Methods of... | 01/13/2009 |
| 7473681 | Kahalalide F Formulations and uses of kahalalide F. ... | 01/06/2009 |
| 7470664 | HCV NS3 protease inhibitors The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. ... | 12/30/2008 |
| 7452862 | Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological ta... | 11/18/2008 |
| 7446094 | Cytotoxic depsipeptides Compounds of general formula (I) wherein R1, R2, R3 are as defined and R4 groups are each independently selected from NR2, O and S; are of use in treatment of cancers. ... | 11/04/2008 |
| 7442683 | Cyclic peptide A novel cyclic peptide having an antifungal activity, its pharmacologically acceptable salts and antifungal medicinal compositions containing the same. ... | 10/28/2008 |
| 7439227 | Use of selected cyclosporins for the treatment of hepatitis C infection This invention relates to the use in the treatment of HCV infection, either as single active agents or in combination with another active agent, of a cyclosporin having increased cyclophilin binding activity and essentially lacking immunosuppressive activity. ... | 10/21/2008 |
| 7435716 | Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia Novel conjugates of bacterial outer membrane binding peptides, preferably having bacterial sensitization activity, and immune cells chemotactic peptides, and pharmaceutical compositions containing same useful in the treatment of bacteremia and/or septicemia followin... | 10/14/2008 |
| 7429562 | Cyclosporin analog formulations The present invention relates to formulations containing cyclosporin analogs that are structurally similar to cyclosporin A, in particular isomeric mixtures of cyclosporin analogs that are structurally similar to cyclosporin A. The formulations form stable microemul... | 09/30/2008 |
| 7429565 | Antiviral phosphonate analogs The invention is related to phosphorus substituted compounds with antiviral activity, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing su... | 09/30/2008 |
| 7425537 | SH2 domain binding inhibitors Disclosed are compounds for SH2 domain binding inhibition, for example, a compound of formula (I), wherein R1 is a lipophile; R2, in combination with the phenyl ring, is a phenylphosphate mimic group or a protected phenylphosphate mimic group; ... | 09/16/2008 |
| 7419954 | peptides for bacterial interference The present invention provides a cyclic peptide comprising the structure: wherein X is selected from the group consisting of an amino acid, an amino acid analog, a peptidomimetic and a non-amide isostere, Z is selected from... | 09/02/2008 |
| 7417025 | Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions The invention relates to the use of a peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues, said peptide comprising a B epitope of a poly-α2,8 sialic acid attached to NCAM, which is recognized by an ant... | 08/26/2008 |
| 7417024 | Template-fixed peptidomimetics as inhibitors of serine proteases Template-fixed β-hairpin peptidomimetics of the general formulae (I), wherein Z is a template-fixed chain of 7 to 11 α-amino acid residues which, depending on their positions in the chain (counted starting from the N-terminal amino acid) are Gly, or Pro, or of cer... | 08/26/2008 |
| 7414023 | Peptide ligands for prostate specific antigen The present invention relates to novel peptide ligands for prostate specific antigen (PSA) binding specifically with it and enhancing its enzyme activity, to a process for preparation of these peptides, to diagnostic and pharmaceutical compositions comprising these ... | 08/19/2008 |
| 7408025 | Lipopeptides as antibacterial agents The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel... | 08/05/2008 |
| 7405200 | Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis A method of treating cancer in situ and cervicitis is disclosed. A pharmaceutical composition comprising at least one substance with oxytocin activity against cancer in situ and cervicitis and compound of the formula SEQ ID NO:2 is also disclosed. ... | 07/29/2008 |
| 7405201 | Antibacterial macrocycles The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions comprising them, and their use in the treatment of diseases in humans or animals. ... | 07/29/2008 |
| 7381703 | Aplidine for multiple myeloma treatment Aplidine and aplidine analogues are used in the manufacture of a medicament for treating multiple myeloma. ... | 06/03/2008 |
| 7375081 | Therapeutic combination of a pneumocandin derivative and an antifungal agent There is described antifungal combination use of known antifungal agents such as the azoles or polyenes in combination with a lipopeptide compound antifungal agent. More particularly, the invention relates to antifungal combination use of azoles such as fluconazole,... | 05/20/2008 |
| 7368426 | Methods for the therapeutic use of cyclosporine components Methods of treating humans or animals having rheumatoid arthritis are disclosed which include topically administering a therapeutically effective amount of a cyclosporine component to the human or animal, thereby treating the rheumatoid arthritis. ... | 05/06/2008 |
| 7368422 | Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity Semi-synthetic glycopeptides that have antibacterial activity are based on modifications of a rearranged vancomycin or desmethyl-vancomycin scaffold, in particular, alkylation or acylation of the amino substituent on the amino-substituted sugar moiety on this scaffo... | 05/06/2008 |
| 7368423 | Composition and method for treating chronic allograft rejection The invention provides a composition and a method for preventing or ameliorating the causes of chronic allograft rejection of a donor organ by a transplant recipient. The method includes concomitant administration to the allograft recipient of therapeutically effect... | 05/06/2008 |
| 7368425 | Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis The present disclosure teaches analogs of human chemokines and methods of using them in the prevention, treatment, and ameliorization of diseases that can benefit from therapeutic angiogenesis. The teachings are generally directed to compositions comprising SDF-1 mi... | 05/06/2008 |
| 7364747 | Process and product for inhibiting or preventing bacterial infections The combination of a polymyxin composition and a hop composition produces unexpected and synergistic activity against gram positive bacteria. ... | 04/29/2008 |
| 7361636 | Cyclosporin alkynes and their utility as pharmaceutical agents The compounds of the present invention are represented by the chemical structure found in Formula I: or a pharmaceutically acceptable salt thereof, with X, R0, and R1 defined herein. ... | 04/22/2008 |
| 7358229 | Deuterated cyclosporin analogs and their use as immunomodulating agents Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical a... | 04/15/2008 |
| 7358284 | Particulate acellular tissue matrix A method of processing an acellular tissue matrix to give a particulate acellular tissue matrix includes: cutting sheets of dry acellular tissue matrix into strips; cryofracturing the dry acellular tissue matrix strips at cryogenic temperatures; separating the resul... | 04/15/2008 |
